Bayer gets European Commission nod for Monsanto deal

New Delhi: German chemical and pharma major Bayer today said it has received “conditional” approval from the European Commission for its proposed USD 66 billion acquisition of US-based biotech major Monsanto.

India is among the countries that are yet to give the nod.

Bayer and Monsanto are working closely with the authorities in the US with the goal of closing the transaction in the second quarter of 2018, the company said.

“Receipt of the European Commission’s approval is a major success and a significant milestone, Bayer CEO Werner Baumann said in a statement.

Together with Monsanto, we want to help farmers across the world grow more nutritious food in a more sustainable way that benefits both consumers and the environment,” he said.

According to Bayer, the conditions cover in particular the divestment of certain Bayer businesses, including the global field crop seeds business such as canola, cotton, and soybean (with minor exceptions restricted to the Asia region), the R&D platform for hybrid wheat, the global vegetable seeds business, the global glufosinate ammonium business as well as certain glyphosate-based herbicides in Europe, predominantly for industrial use.

In addition, Monsanto’s global business with the nematicide NemaStrike must be divested.

The conditions also stipulate the transfer of three Bayer research projects in the area of non-selective herbicides and the granting of a license to Bayer’s digital farming portfolio. BASF is the intended purchaser of these assets.

The transaction remains subject to customary closing conditions, including receipt of required regulatory approvals, the company added.

In India, both entities have presence in production and sale of vegetable seeds, cotton seeds as well as in production and sale of non-selective herbicides, according to that notice.

Bayer group is present in India since 1896 and has two divisions — crop science and pharmaceuticals. The group has one listed entity in India — Bayer CropScience Ltd that posted a revenue from operation of nearly Rs 3,000 crore last fiscal.

  • Related Posts

    Jharkhand HC orders FIRover children being given HIV-infected blood during transfusions

    Ranchi: The Jharkhand High Court on February 4 ordered the registration of a first information report (FIR) in a case where five children were infected with HIV after getting blood transfusions…

    Narco Syndicate indulged in supply of Contraband NRX medicines dismantled, arrested two key operatives

    New Delhi: In an effective and decisive action, the Anti-Narcotics Task Force (ANTF) of the Crime Branch has successfully dismantled a major Narco-syndicate indulged in supply of contraband medicines. This…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Jharkhand HC orders FIRover children being given HIV-infected blood during transfusions

    Jharkhand HC orders FIRover children being given HIV-infected blood during transfusions

    Narco Syndicate indulged in supply of Contraband NRX medicines dismantled, arrested two key operatives

    Narco Syndicate indulged in supply of Contraband NRX medicines dismantled, arrested two key operatives

    Health dept cracks down on ‘Sojat’ henna fraud by pvt cos

    Health dept cracks down on ‘Sojat’ henna fraud by pvt cos

    BDMAI’s e-marketing portal to promote Indian pharma products and services

    BDMAI’s e-marketing portal to promote Indian pharma products and services

    FIR against pharma dealer for supplying dubious snake antidote to govt

    FIR against pharma dealer for supplying dubious snake antidote to govt

    Indigenous Robotic Surgery is Mantra for Accessible Cancer Care in India

    Indigenous Robotic Surgery is Mantra for Accessible Cancer Care in India